S&P 500
7,486.70
+0.45%
Dow Jones
52,417.60
+0.23%
Nasdaq 100
30,191.00
+1.31%
Russell 2000
3,018.47
+0.30%
FTSE 100
10,533.00
-0.07%
Nikkei 225
71,039.80
+0.54%
Live Nasdaq Composite: Markets Take Breather After Impressive Q2 Showing on Easing Oil Outlook
Alignment Healthcare

Alignment Healthcare (ALHC) Q1 2026 Earnings

Reported Apr 30, 2026 at 4:01 PM ET · SEC Source

Q1 26 EPS

$0.05

MISS 42.86%

Est. $0.09

Q1 26 Revenue

$1.24B

BEAT +1.42%

Est. $1.22B

vs S&P Since Q1 26

+6.2%

BEATING MARKET

ALHC +9.5% vs S&P +3.2%

Market Reaction

Did ALHC Beat Earnings? Q1 2026 Results

Alignment Healthcare posted a mixed first quarter for 2026, delivering a revenue beat but falling short on the bottom line as investors weighed strong membership growth against a softer-than-expected profit result. The value-based care company report… Read more Alignment Healthcare posted a mixed first quarter for 2026, delivering a revenue beat but falling short on the bottom line as investors weighed strong membership growth against a softer-than-expected profit result. The value-based care company reported revenue of $1.24 billion, up 33.3% year over year and modestly ahead of the $1.22 billion consensus, while earnings per share of $0.05 missed the $0.09 analyst estimate by 42.86%, snapping a four-consecutive-quarter streak of EPS beats. The headline profit figure, however, obscured meaningful operational progress; GAAP net income came in at $11.42 million compared to a net loss of $9.35 million a year ago, supported by Medicare Advantage membership climbing 30.9% to roughly 284,800 and a medical benefits ratio that improved 25 basis points to 88.2%. Adjusted EBITDA nearly doubled to $37.85 million, up 87.6% from the prior-year period. Looking ahead, management raised the midpoint of all full-year 2026 guidance metrics, projecting revenue of $5.16 billion to $5.21 billion and adjusted EBITDA of $138 million to $163 million, signaling confidence in sustained growth as the company expands its technology-enabled care model beyond its California base.

Key Takeaways

  • • Medicare Advantage membership grew 30.9% year-over-year to approximately 284,800 members
  • • Medical benefits ratio improved 25 basis points year-over-year to 88.2%
  • • Adjusted EBITDA grew 87.6% year-over-year to $37.9 million
  • • Disciplined execution across sales, clinical operations and cost management
  • • Operating cash flow surged to $128.7 million from $16.6 million in Q1 2025

ALHC Forward Guidance & Outlook

Alignment Healthcare raised the midpoint of all full-year 2026 guidance metrics. For Q2 2026, the company expects health plan membership of 288,000–290,000, revenue of $1,295–$1,315 million, adjusted gross profit of $167–$177 million, and adjusted EBITDA of $50–$60 million. For full-year 2026, guidance calls for membership of 294,000–299,000, revenue of $5,160–$5,205 million, adjusted gross profit of $620–$650 million, and adjusted EBITDA of $138–$163 million.

24/7 Wall St

ALHC YoY Financials

Q1 2026 vs Q1 2025, source: SEC Filings

24/7 Wall St

ALHC Revenue by Segment

With YoY comparisons, source: SEC Filings

Q1 25 Q1 26

“Our first-quarter performance demonstrates that Alignment continues to grow with discipline. We expanded our profitability by executing across sales, clinical operations and cost management, even as the Medicare Advantage environment continues to change. We delivered strength within our results even while we are investing in our people, processes and technologies. The improvements we are making across each of these areas will position us to scale the business and achieve our embedded earnings potential.”

— John Kao, Q1 2026 Earnings Press Release

Back to ALHC Stock Page